SUMMARY Hydroxyurea (HU) is an inhibitor of DNA synthesis, which can inhibit the enzyme ribonucleotide reductase, reduce the syntheses of all four deoxyribonucleoside diphosphates (dNDP), and disturb the balance of the dNTP pool. We have studied the effect of HU on the common fragile site at 3p14 (FRA3B) and have found that G2 treatment with HU increased not only the frequency of chromosomal aberration but also the expression of FRA3B in both complete and folate deficient media. There is a synergistic effect between HU and growth in folate deficient medium on the induction of FRA3B. Our results suggest that the inhibition of DNA repair, including the inhibition in G2 phase, plays an important role in the expression of FRA3B, supporting other authors' data on the effect of other DNA repair inhibitors, such as aphidicolin, caffeine, 1-,B-D-arabinofuranosylcytosine, and 5-fluorodeoxyuridine, on the expression of FRA3B.
Common fragile sites, sometimes called 'hot points' in previous articles, are non-random chromosome lesions occurring at specific chromosome sites, for example, 3pl4, 6q26, and 16q23. 1-3 Some inhibitors of DNA repair, such as 1-P3-D-arabinofuranosylcytosine (araC),4 caffeine (caff),5 aphidicolin (Aph),6 and 5-fluorodeoxyuridine (FUdR),78 can induce the expression of common fragile sites including the fragile site at 3pl4 (FRA3B).
Hydroxyurea (HU) is a DNA synthesis inhibitor, acting by inhibiting the enzyme ribonucleotide reductase, which catalyses the reduction of ribonucleoside diphosphates to the corresponding deoxyribonucleoside diphosphates. It can increase the frequencies of both spontaneous and induced chromosomal aberrations during G2 phase.9 To date, there have been no reports about the effect of HU on common fragile sites. In this paper, we report our studies on the effect of HU on the expression of FRA3B in which we found that HU increases not only the frequency of chromosomal aberrations but also significantly increases the expression of FRA3B.
Materials and methods
Lymphocyte cultures were established from fresh blood samples from eight healthy donors (four males and four females). For each blood sample the cultures were divided into four groups: cultures in minimal essential complete medium (FA+); cultures in complete medium treated with HU during G2 phase (FA+ +HU); cultures in minimal essential folate deficient medium (FA-); and cultures in folate deficient medium treated with HU during G2 phase (FA-+HU).
The cultures in folate deficient medium were set up by adding 0*5 ml of heparinised venous blood to flasks containing 5 ml of minimal essential medium without folic acid (MEM-FA) (Gibco), 0-25 ml newborn calf serum, 0-05 ml glutamine (0.03 gIml), 0-05 ml penicillin and streptomycin (10 000 IU/ml), and 0*15 ml of PHA (Gibco). For the cultures in complete medium, 0-06 ml folic acid (0-1 mg/ml) was added to folate deficient medium at a final concentration of 1 mg/l. The cultures were incubated for 96 hours at 37°C. For the HU treated cultures, HU was added at a final concentration of 4 x 10-3 mol/l two hours before harvest. Colcemid at a final concentration of 0*3 sg/ml was added to all cultures for the last hour.
The slides were stained with Giemsa and 200 metaphases with 45 to 47 centromeres from each group of cultures were examined. All types of chromosome aberration, including chromatid gaps and isochromatid gaps, and FRA3B were scored.
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Results and discussion
According to the widened definition and classification of fragile sites,"' we would call the non-random gaps and breaks on human chromosomes which were studied in our laboratoryl-3 common fragile sites instead of 'hot points'.
HU, an inhibitor of both replicative and repair DNA synthesis, can inhibit the enzyme ribonucleotide reductase, reduce the synthesis of all four deoxyribonucleoside diphosphates (dNDP), and deplete the dNTP pool in cells. This effect would limit DNA synthesis activity leading to a dramatic decrease in replicative DNA synthesis. The results of the study of Erixon and Ahnstrom" also clearly indicate that HU affects repair synthesis. However, the idea that HU inhibits DNA repair has been challenged by the work of Smith.'2 He found that repair synthesis was increased by 25 to 40% in HU treated cells over a wide range of UV doses and post UV incubation times. Even 100 mmol/l HU did not significantly decrease repair synthesis. To date, the mechanism of inhibition of DNA repair by HU is not yet fully understood. As suggested by Erixon and Ahnstrom," the rate of DNA repair polymerisation falls off as the size of the dNTP pool is reduced by HU. The exonucleolytic digestion or DNA strand displacement proceeds faster than the polymerisation does. Thus, ligation is delayed, patch size increases,'3 and the repair site remains open five times longer than normal." In general, the reduction of dNTP pool size by HU acts on DNA repair by lengthening the time required to complete a repair event but does not materially affect the total amount of repair synthesis. This would increase the number of repair sites unligated at a given time,'2 causing the accumulation of single strand DNA breaks and chromosome aberrations.
The frequencies of chromosomal aberrations in the four culture groups are listed in table 1. In the FA++HU and FA-+HU groups, the frequencies of chromosome aberrations, including gaps and isochromatid gaps, are obviously higher than those in the corresponding controls. Our results are consistent with the reports of Kihlman and Natarajan and Kihlman et al14 and indicate that in this experiment the DNA repair in G2 is inhibited.
The expression of FRA3B induced by HU is shown in table 2. The mean frequencies of FRA3B in the FA-+HU and FA++HU groups are very much higher than those in the FA-(p<0002) and the FA+ (p<0-05) groups, respectively. In the first 200 metaphases scored, the positive rate of FRA3B in the eight subjects studied was 88% (7/8) for the FA++HU group and 13% (1/8) for the FA+ group.
These findings indicate that HU can induce the expression of FRA3B and enhance its frequency both in folate deficient and in complete medium.
Aph and araC are both inhibitors of DNA repair by inhibiting the enzyme DNA polymerase a. The frequencies of both spontaneous and induced chromosomal aberrations can be increased by Aph and araC during G2 phase.9 The significantly increased frequencies of FRA3B induced by the treatment with araC or Aph were also found in lymphocytes cultured in vitro.4 6 These results indicate that the low DNA polymerase a activity and inefficient repair of DNA synthesis during the cell cycle or G2 phase play a role in the expression of FRA3B.
; Caffeine can shorten the time available for repair and increase the frequencies of both spontaneous and induced chromosomal aberrations during G2 phase.9 Yunis and Soreng5 found that caffeine is an inhibitor of DNA post-replication repair and that it can enhance the expression of common fragile sites, especially at 3pl4 and 16q23. FUdR is a powerful DNA repair inhibitor, specifically inhibiting thymidylate synthetase which catalyses the synthesis of thymidylic acid from deoxyuridylic acid. It can increase the frequencies of both spontaneous and induced chromosomal aberrations during G2 phase.9 Daniel et al7 and Smeets et a18 found that
FUdR can enhance the expression of FRA3B and other sites. The effect of DNA repair inhibitors, HU, Aph, araC, caffeine, and FUdR on the expression of common fragile sites might suggest that inefficient DNA repair, including inefficient DNA repair synthesis during G2 phase, plays a very important role in the expression of FRA3B.
As with HU, G2 treatment with 2'-deoxyadenosine (dAdo) can increase the frequency of chromosomal aberrations. 19 Although the chemical structures of HU and dAdo vary significantly, both inhibit DNA repair synthesis by inhibition of the enzyme ribonucleotide reductase. On the basis of the effect of HU on FRA3B, we predict that dAdo could also induce the expression of FRA3B.
When lymphocyte cultures are maintained in complete medium, the rate of FRA3B in a population is very low. Although araC could induce FRA3B in complete medium, the rate of FRA3B in the seven blood donors studied was only 57% (4/7) and there was no significant difference between araC treated and untreated groups (table 3)4; the induction of FRA3B by HU in complete medium seems to be more efficient than by araC. FRA3B was observed in seven of eight blood donors studied and the frequency of the HU treated group was significantly different from that of the HU untreated group (p<005, table 2). It appears that inhibition of ribonucleotide reductase by HU has more effect on the expression of FRA3B than inhibition of DNA polymerase a by araC.
In this experiment synergism between HU and growth in the folate deficient medium was tested. According to the formula of Kihlman and Andersson'5: Cf=Eil +i2/(Eil + Ei2), where Cf is the combination factor, Eil +i2 is the effect of the combined treatment, and Eil+Ei2 the sum of the effects of the inhibitors il and i2 alone. The Cf of HU and folate deficiency in combination is 3-1. This Cf value indicates that there is a synergistic effect between HU and growth in folate deficient medium on the induction of FRA3B. There are also similar synergistic effects between araC, Aph, or caffeine and growth in folate deficient medium.46 It seems that more DNA damage is induced when cells grow in folate deficient medium. Folic acid is converted to 5,10-methylenetetrahydrofolate in vivo. The latter serves as a co-enzyme of thymidilate synthetase which catalyses the methylation of dUMP to dTMP. Folic acid deficiency would block the methylation of This work was supported by the National Foundation of Natural Science of China 3860196.
